Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Pulmonary Embolism: Role of Catheter-Based Interventions

Baylor College of Medicine

P. Loyalka

ASH 2024 Summary: Full or Reduced Dose Apixaban or Rivaroxaban for E…

2024 ASH Annual Meeting Insights Hub

J. Schaefer

CHEST 2024 Insights: Post COVID Cardiac Complications

CHEST Annual Meeting Insights

N. Ramesh

Updates in Thrombosis and Anticoagulation

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

D. Garcia

Thrombophilia Screening: Best Practices and Who Should Be Tested

COR2ED The Heart of Medical Education

S. Middeldorp, J. Connors

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

Is There a Role for Splenectomy in ITP?

Platelet Disorder Support Association (PDSA)

C. Kessler

Cancer Associated Thrombosis and Pulmonary Embolism Management

Scripps Health

G. Jay Bishop

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

Recent Advances in Classical Hematology

Indy Hematology Review

R. Brodsky

ASH 2024 Summary: Overview of Non-Surgical Management of Heavy Menst…

2024 ASH Annual Meeting Insights Hub

A. Wheeler

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

Key Insights on the FDA Approval of Marstacimab for Hemophilia

Akshat Jain

Management of Treatment-Naive ITP Patients

Weill Cornell Medicine Oncology & Hematology

J. Bussel

Natural History of ITP: Navigating the Journey

Platelet Disorder Support Association (PDSA)

D. Kuter

Are All New ITP Treatments Better Than Old Ones: Other Treatments to…

Platelet Disorder Support Association (PDSA)

H. Liebman